Atlas Trials

Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects

Clinical trial NCT04510402 · UNKNOWN

Trial details

NCT number
NCT04510402
Sponsor
Brigham and Women's Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Covid19Povidone Iodine Adverse Reaction
Start date
2020-08-01
Primary completion
2021-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.